Scored 6/10 on whether it helps or hurts everyday people.
The Cheaper Drugs Bill
Patients could get cheaper drugs if patent rules change
Affordable Prescriptions for Patients Act
Mixed: some good, some bad ·
If passed, the bill would change patent rules so drug makers can’t block cheaper copies, helping patients pay less for medicines.
Our take
What we think, in plain words.
Right now, drug makers can use patents to keep prices high; this bill would let cheaper versions be made, lowering costs for everyday patients but cutting profits for big pharma.
Take action
Add your name. At 100 signatures we compile this petition and deliver it to the office — and every signer gets a message to send their own representatives.
0 of 100 in‑district signatures
Step 1 · Pick your position
Step 2 · Add your name
Sign in to oppose this billPicking a side above doesn't sign anything yet — a free account records your name on the petition and keeps it one signature per person. We'll bring you straight back here with your choice saved.
The facts
What the bill actually says, no spin.
- Bill number is SB1041.
- Sponsored by Senators John Cornyn, Richard Blumenthal, Chuck Grassley, and Richard Durbin.
- Current stage is Engrossed after Senate passed it with unanimous consent.
- Amends Title 35 of the U.S. Code that covers patents on biological products.
- Would change how patents on drugs are enforced.
In the news
Scanning the news for this bill…
Headlines gathered from across the news, starting points to explore, not endorsements. Always read the official text before acting.
Sources
Read it yourself: the official bill and records.
This bill is in the Federal (Congress) Bill Book 2026
The best and worst Federal (Congress) bills of 2026, one page each — our take on the left, the bill on the right, and room for your notes. No email needed.
Get the free PDF →